An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for supplier links, while also receiving discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Worries
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals administering products of uncertain source.
Several experts said the demand for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.
Platform Response and Content Elimination
According to TikTok, the platform has taken down violative content and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Research also discovered communities with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at home.
After moments of joining one community, a seller posted contact information, where most transactions occur. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or previous experience.
Product Information and Costs
Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram said it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has already encountered individuals harmed by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially significant health risks”.
